Patents by Inventor Michael BATTLES

Michael BATTLES has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250243281
    Abstract: The invention relates generally to anti-CD161 antibodies, pharmaceutical compositions comprising such antibodies, and methods of using such antibodies for treating disorders associated with or mediated by CD161, for example, certain cancers.
    Type: Application
    Filed: April 15, 2025
    Publication date: July 31, 2025
    Inventors: Alison TISDALE, Uli BIALUCHA, George PUNKOSDY, Alexandria FUSCO, Frano IRVINE, Emily ROSENTRATER, Elizabeth SCANLON, Michael BATTLES
  • Publication number: 20250122290
    Abstract: The invention relates generally to anti-CD161 antibodies, pharmaceutical compositions comprising such antibodies, and methods of using such antibodies for treating disorders associated with or mediated by CD161, for example, certain cancers.
    Type: Application
    Filed: December 19, 2024
    Publication date: April 17, 2025
    Inventors: Alison TISDALE, Uli BIALUCHA, George PUNKOSDY, Alexandria FUSCO, Frano IRVINE, Emily ROSENTRATER, Elizabeth SCANLON, Michael BATTLES
  • Patent number: 12215159
    Abstract: The invention relates generally to anti-CD161 antibodies, pharmaceutical compositions comprising such antibodies, and methods of using such antibodies for treating disorders associated with or mediated by CD161, for example, certain cancers. In addition, the invention also relates to expression vectors and host cells for making these antibodies.
    Type: Grant
    Filed: February 21, 2024
    Date of Patent: February 4, 2025
    Assignee: IMMUNITAS THERAPEUTICS, INC.
    Inventors: Alison Tisdale, Uli Bialucha, George Punkosdy, Alexandria Fusco, Frano Irvine, Emily Rosentrater, Elizabeth Scanlon, Michael Battles
  • Publication number: 20240279346
    Abstract: The invention relates generally to anti-CD161 antibodies, pharmaceutical compositions comprising such antibodies, and methods of using such antibodies for treating disorders associated with or mediated by CD161, for example, certain cancers.
    Type: Application
    Filed: February 21, 2024
    Publication date: August 22, 2024
    Inventors: Alison TISDALE, Uli BIALUCHA, George PUNKOSDY, Alexandria FUSCO, Frano IRVINE, Emily ROSENTRATER, Elizabeth SCANLON, Michael BATTLES
  • Patent number: 11857571
    Abstract: Antigen binding fragments, chimeric antigen receptors, and bi-specific T-cell engagers having specificity for MICA and methods for using the same in the diagnosis and treatment of disorders associated with MICA and/or MICB expression are provided.
    Type: Grant
    Filed: August 17, 2020
    Date of Patent: January 2, 2024
    Assignee: THE TRUSTEES OF DARTMOUTH COLLEGE
    Inventors: Charles Sentman, Michael Battles
  • Publication number: 20210030800
    Abstract: Antigen binding fragments, chimeric antigen receptors, and bi-specific T-cell engagers having specificity for MICA and methods for using the same in the diagnosis and treatment of disorders associated with MICA and/or MICB expression are provided.
    Type: Application
    Filed: August 17, 2020
    Publication date: February 4, 2021
    Inventors: Charles SENTMAN, Michael BATTLES
  • Patent number: 10744157
    Abstract: Antigen binding fragments, chimeric antigen receptors, and bi-specific T-cell engagers having specificity for MICA and methods for using the same in the diagnosis and treatment of disorders associated with MICA and/or MICB expression are provided.
    Type: Grant
    Filed: March 25, 2016
    Date of Patent: August 18, 2020
    Assignee: THE TRUSTEES OF DARTMOUTH COLLEGE
    Inventors: Charles Sentman, Michael Battles
  • Publication number: 20180085400
    Abstract: Antigen binding fragments, chimeric antigen receptors, and bi-specific T-cell engagers having specificity for MICA and methods for using the same in the diagnosis and treatment of disorders associated with MICA and/or MICB expression are provided.
    Type: Application
    Filed: March 25, 2016
    Publication date: March 29, 2018
    Inventors: Charles SENTMAN, Michael BATTLES